![James Caruso](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James Caruso
Algemeen Directeur bij CELLECTAR BIOSCIENCES, INC.
Vermogen: 152 084 $ op 31-05-2024
Actieve functies van James Caruso
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CELLECTAR BIOSCIENCES, INC. | Directeur/Bestuurslid | 15-06-2015 | - |
Algemeen Directeur | 15-06-2015 | - | |
President | 15-06-2015 | - | |
Hip Innovation Technology LLC | Directeur/Bestuurslid | 01-06-2015 | - |
Oprichter | 01-08-2010 | - | |
Operationeel Directeur | 01-08-2010 | 01-06-2015 |
Loopbaan van James Caruso
Eerdere bekende functies van James Caruso
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Allos Therapeutics, Inc.
![]() Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Corporate Officer/Principal | 05-06-2006 | 24-08-2010 |
Bone Care International, Inc.
![]() Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Bone Care International, Inc. developed innovative therapeutic products. Its products included Hectorol Injections and Capsules. The company was located in Middleton, WI. | Verkoop & Marketing | 01-06-2002 | - |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Verkoop & Marketing | 01-06-2001 | 01-06-2002 |
BASF Pharma Ltd.
![]() BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Verkoop & Marketing | 01-06-2000 | 01-05-2001 |
Knoll Pharmaceutical Co. | Verkoop & Marketing | 01-01-2000 | 01-01-2001 |
Opleiding van James Caruso
University of Nevada | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Verenigd Koninkrijk | 2 |
Operationeel
Sales & Marketing | 4 |
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 6 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CELLECTAR BIOSCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Bone Care International, Inc.
![]() Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Bone Care International, Inc. developed innovative therapeutic products. Its products included Hectorol Injections and Capsules. The company was located in Middleton, WI. | Health Technology |
Allos Therapeutics, Inc.
![]() Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Health Technology |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Hip Innovation Technology LLC | |
BASF Pharma Ltd.
![]() BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Health Technology |
Knoll Pharmaceutical Co. |
- Beurs
- Insiders
- James Caruso
- Ervaring